Sena-Esteves M - Search Results

1

Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy.

Kramm CM, Chase M, Herrlinger U, Jacobs A, Pechan PA, Rainov NG, Sena-Esteves M, Aghi M, Barnett FH, Chiocca EA, Breakefield XO. Kramm CM, et al. Hum Gene Ther. 1997 Nov 20;8(17):2057-68. doi: 10.1089/hum.1997.8.17-2057. Hum Gene Ther. 1997. PMID: 9414254

2

Critical issues in gene therapy for neurologic disease.

Hsich G, Sena-Esteves M, Breakefield XO. Hsich G, et al. Hum Gene Ther. 2002 Mar 20;13(5):579-604. doi: 10.1089/10430340252837198. Hum Gene Ther. 2002. PMID: 11916483 Review.

3

Potentiated gene delivery to tumors using herpes simplex virus/Epstein-Barr virus/RV tribrid amplicon vectors.

Hampl JA, Camp SM, Mydlarz WK, Hampl M, Ichikawa T, Chiocca EA, Louis DN, Sena-Esteves M, Breakefield XO. Hampl JA, et al. Hum Gene Ther. 2003 May 1;14(7):611-26. doi: 10.1089/104303403321618137. Hum Gene Ther. 2003. PMID: 12804144

4

Mutant sodium channel for tumor therapy.

Tannous BA, Christensen AP, Pike L, Wurdinger T, Perry KF, Saydam O, Jacobs AH, García-Añoveros J, Weissleder R, Sena-Esteves M, Corey DP, Breakefield XO. Tannous BA, et al. Mol Ther. 2009 May;17(5):810-9. doi: 10.1038/mt.2009.33. Epub 2009 Mar 3. Mol Ther. 2009. PMID: 19259066 Free PMC article.

5

Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene.

Boviatsis EJ, Park JS, Sena-Esteves M, Kramm CM, Chase M, Efird JT, Wei MX, Breakefield XO, Chiocca EA. Boviatsis EJ, et al. Cancer Res. 1994 Nov 15;54(22):5745-51. Cancer Res. 1994. PMID: 7954393

6

Herpes vector-mediated delivery of marker genes to disseminated central nervous system tumors.

Kramm CM, Rainov NG, Sena-Esteves M, Chase M, Pechan PA, Chiocca EA, Breakefield XO. Kramm CM, et al. Hum Gene Ther. 1996 Feb 10;7(3):291-300. doi: 10.1089/hum.1996.7.3-291. Hum Gene Ther. 1996. PMID: 8835217

7

Long-term survival in a rodent model of disseminated brain tumors by combined intrathecal delivery of herpes vectors and ganciclovir treatment.

Kramm CM, Rainov NG, Sena-Esteves M, Barnett FH, Chase M, Herrlinger U, Pechan PA, Chiocca EA, Breakefield XO. Kramm CM, et al. Hum Gene Ther. 1996 Oct 20;7(16):1989-94. doi: 10.1089/hum.1996.7.16-1989. Hum Gene Ther. 1996. PMID: 8930659

8

Gene therapy for brain tumors.

Kramm CM, Sena-Esteves M, Barnett FH, Rainov NG, Schuback DE, Yu JS, Pechan PA, Paulus W, Chiocca EA, Breakefield XO. Kramm CM, et al. Brain Pathol. 1995 Oct;5(4):345-81. doi: 10.1111/j.1750-3639.1995.tb00615.x. Brain Pathol. 1995. PMID: 8974620 Review.

9

Green fluorescent protein as a reporter for retrovirus and helper virus-free HSV-1 amplicon vector-mediated gene transfer into neural cells in culture and in vivo.

Aboody-Guterman KS, Pechan PA, Rainov NG, Sena-Esteves M, Jacobs A, Snyder EY, Wild P, Schraner E, Tobler K, Breakefield XO, Fraefel C. Aboody-Guterman KS, et al. Neuroreport. 1997 Dec 1;8(17):3801-8. doi: 10.1097/00001756-199712010-00029. Neuroreport. 1997. PMID: 9427374

10

New prodrug activation gene therapy for cancer using cytochrome P450 4B1 and 2-aminoanthracene/4-ipomeanol.

Rainov NG, Dobberstein KU, Sena-Esteves M, Herrlinger U, Kramm CM, Philpot RM, Hilton J, Chiocca EA, Breakefield XO. Rainov NG, et al. Hum Gene Ther. 1998 Jun 10;9(9):1261-73. doi: 10.1089/hum.1998.9.9-1261. Hum Gene Ther. 1998. PMID: 9650611

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

163 results

Search Page

Filters